Group One Trading, L.P. Galera Therapeutics, Inc. Transaction History
Group One Trading, L.P.
- $2.68 Billion
- Q1 2024
A detailed history of Group One Trading, L.P. transactions in Galera Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 32,720 shares of GRTX stock, worth $7,198. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,720
Previous 64,897
49.58%
Holding current value
$7,198
Previous $9,000
55.56%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding GRTX
# of Institutions
38Shares Held
10.7MCall Options Held
10.3KPut Options Held
0-
Gsa Capital Partners LLP London, X03.63MShares$799,1770.04% of portfolio
-
Blackstone Inc New York, NY1.68MShares$369,3760.0% of portfolio
-
Tekla Capital Management LLC898KShares$197,6420.11% of portfolio
-
Abrdn PLC898KShares$197,6420.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3613KShares$134,9090.08% of portfolio
About Galera Therapeutics, Inc.
- Ticker GRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,821,600
- Market Cap $5.9M
- Description
- Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...